Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503802 · ClinicalTrials.gov registry record · Phase 2
Randomized Clinical Trial of Nasal Turbinate Reduction to Improve Continuous Positive Airway Pressure (CPAP) Outcomes for Sleep Apnea
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 242
- Enrollment target
NCT00503802 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 242 participants.
The verdict
NCT00503802, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 242 participants
- Enrollment target
Study Summary
Obstructive sleep apnea occurs in 2-4% of middle age adults and results in significant morbidity and mortality. The first line therapy is provision of continuous positive airway pressure (CPAP) via a nasal mask chronically. Nasal resistance related to nasal turbinate enlargement may compromise CPAP treatment. This randomized double-blind sham-placebo-controlled trial tests the hypothesis that nasal turbinate reduction improves the nasal passage, CPAP use, and sleep apnea quality of life in newly diagnosed sleep apnea patients who are recommended CPAP therapy.
Interventions
- PROCEDURE Radiofrequency Turbinate Reduction
- PROCEDURE Sham RF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00503802
The ClinicalTrials.gov registry entry for NCT00503802 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radiofrequency Turbinate Reduction is the first listed.
NCT00503802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00503802 about?
NCT00503802 is a clinical study titled "Randomized Clinical Trial of Nasal Turbinate Reduction to Improve Continuous Positive Airway Pressure (CPAP) Outcomes for Sleep Apnea". Obstructive sleep apnea occurs in 2-4% of middle age adults and results in significant morbidity and mortality. The first line therapy is provision of continuous positive airway pressure (CPAP) via a nasal mask chronically. Nasal resistance related to nasal turbinate enlargement may compromise CPAP ...
What is the current status of trial NCT00503802?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 242 participants. The study started on 2007-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00503802?
The interventions under investigation include: Radiofrequency Turbinate Reduction (PROCEDURE), Sham RF (PROCEDURE).
Who is sponsoring clinical trial NCT00503802?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.